151 related articles for article (PubMed ID: 38707233)
1. Prognostic factors of conversion surgery for stage IV gastric cancer: A multi-institutional retrospective analysis.
Takeno A; Motoori M; Kishi K; Omori T; Hirao M; Masuzawa T; Fujitani K; Yamamato K; Kurokawa Y; Doki Y
Ann Gastroenterol Surg; 2024 May; 8(3):431-442. PubMed ID: 38707233
[TBL] [Abstract][Full Text] [Related]
2. Conversion surgery for stage IV gastric cancer: a multicenter retrospective study.
Kano Y; Ichikawa H; Hanyu T; Muneoka Y; Ishikawa T; Aizawa M; Matsuki A; Yabusaki H; Bamba T; Nakagawa S; Kobayashi K; Kuwabara S; Makino S; Kawachi Y; Naito T; Tani T; Hirukawa H; Tada T; Shimada Y; Sakata J; Wakai T
BMC Surg; 2022 Dec; 22(1):428. PubMed ID: 36517780
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of very early recurrence after conversion surgery for stage IV gastric cancer.
Morito A; Eto K; Iwatsuki M; Toihata T; Kosumi K; Iwagami S; Baba Y; Miyamoto Y; Yoshida N; Baba H
Ann Gastroenterol Surg; 2024 Mar; 8(2):214-220. PubMed ID: 38455498
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of conversion gastrectomy for treatment of Stage IV advanced gastric cancer].
Funaki H; Fujita J; Morioka E; Kaida D; Ohnishi T; Ohno Y; Tomita Y; Noguchi M; Fujita H; Kinami S; Nakano Y; Ueda N; Kosaka T
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1615-7. PubMed ID: 24393866
[TBL] [Abstract][Full Text] [Related]
6. Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer.
Chen C; Wang L; Zhang R; Li Q; Zhao YL; Zhang GJ; Li WZ; Geng ZM
Chronic Dis Transl Med; 2019 Sep; 5(3):188-196. PubMed ID: 31891130
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in patients with middle and distal bile duct cancers.
Kwon HJ; Kim SG; Chun JM; Lee WK; Hwang YJ
World J Gastroenterol; 2014 Jun; 20(21):6658-65. PubMed ID: 24914391
[TBL] [Abstract][Full Text] [Related]
8. Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer.
Nakanishi K; Tanaka C; Kanda M; Miyata K; Furukawa K; Maeda O; Shimizu D; Sugita S; Kakushima N; Furune S; Kawashima H; Ando Y; Ebata T; Kodera Y
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958371
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors for Gastric Cancer Patients With One Stage IV Factor who Underwent Conversion Surgery.
Shimoda Y; Fujikawa H; Komori K; Watanabe H; Kano K; Yamada T; Shiozawa M; Morinaga S; Katsumata K; Tsuchida A; Ogata T; Oshima T
Anticancer Res; 2021 Feb; 41(2):1005-1012. PubMed ID: 33517308
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Peritoneal Metastasis in Stage IV Colorectal Cancer Patients With R0 Resection: A Multicenter, Retrospective Study.
Arakawa K; Kawai K; Ishihara S; Hata K; Nozawa H; Oba K; Sugihara K; Watanabe T
Dis Colon Rectum; 2017 Oct; 60(10):1041-1049. PubMed ID: 28891847
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
[TBL] [Abstract][Full Text] [Related]
12. Utility of the proximal margin frozen section for resection of gastric adenocarcinoma: a 7-Institution Study of the US Gastric Cancer Collaborative.
Squires MH; Kooby DA; Pawlik TM; Weber SM; Poultsides G; Schmidt C; Votanopoulos K; Fields RC; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Jin LX; Levine E; Cho CS; Bloomston M; Winslow E; Cardona K; Staley CA; Maithel SK
Ann Surg Oncol; 2014 Dec; 21(13):4202-10. PubMed ID: 25047464
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Significance of CA19-9 and Tumor Size Ratios for Predicting Prognosis After Conversion Surgery in Patients With Stage IV Gastric Cancer.
Okubo K; Arigami T; Matsushita D; Uenosono Y; Yanagita S; Kijima T; Tsuruda Y; Noda M; Sasaki K; Mori S; Kurahara H; Ohtsuka T
Anticancer Res; 2021 Nov; 41(11):5643-5649. PubMed ID: 34732437
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of thoracotomy and thoracoscopic-assisted esophageal surgery in conversion and salvage surgeries: a retrospective study.
Hoshino I; Gunji H; Kuwayama N; Kurosaki T; Tonooka T; Soda H; Takiguchi N; Nabeya Y; Takayama W
World J Surg Oncol; 2022 May; 20(1):163. PubMed ID: 35599328
[TBL] [Abstract][Full Text] [Related]
15. Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study.
Sato Y; Ohnuma H; Nobuoka T; Hirakawa M; Sagawa T; Fujikawa K; Takahashi Y; Shinya M; Katsuki S; Takahashi M; Maeda M; Okagawa Y; Naoki U; Kikuch S; Okamoto K; Miyamoto H; Shimada M; Takemasa I; Kato J; Takayama T
Gastric Cancer; 2017 May; 20(3):517-526. PubMed ID: 27553665
[TBL] [Abstract][Full Text] [Related]
16. International Retrospective Cohort Study of Conversion Therapy for Stage IV Gastric Cancer 1 (CONVO-GC-1).
Yoshida K; Yasufuku I; Terashima M; Young Rha S; Moon Bae J; Li G; Katai H; Watanabe M; Seto Y; Hoon Noh S; Kwang Yang H; Ji J; Baba H; Kitagawa Y; Morita S; Nishiyama M; Kodera Y;
Ann Gastroenterol Surg; 2022 Mar; 6(2):227-240. PubMed ID: 35261948
[TBL] [Abstract][Full Text] [Related]
17. Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients.
Saito M; Kiyozaki H; Takata O; Suzuki K; Rikiyama T
World J Surg Oncol; 2014 Dec; 12():406. PubMed ID: 25551581
[TBL] [Abstract][Full Text] [Related]
18. [The relationship between the index of lymph node metastasis and the prognosis of pancreatic cancer patients after R0 resection].
Ren H; Wang CF
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):474-479. PubMed ID: 32575943
[No Abstract] [Full Text] [Related]
19. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of hepatocellular carcinoma with bile duct tumor thrombus after R0 resection: a matched study.
Wang DD; Wu LQ; Wang ZS
Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):626-632. PubMed ID: 27919852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
